NYSE:OMIOwens & Minor Competitors & Alternatives

Select Medical (NYSE:SEM) and Owens & Minor (NYSE:OMI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, institutional ownership, earnings and profitability.

Earnings and Valuation

This table compares Select Medical and Owens & Minor's top-line revenue, earnings per share and valuation.

Select Medical has higher earnings, but lower revenue than Owens & Minor. Select Medical is trading at a lower price-to-earnings ratio than Owens & Minor, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Select Medical and Owens & Minor, as reported by MarketBeat.com.

Select Medical presently has a consensus price target of $22.00, suggesting a potential upside of 57.48%. Owens & Minor has a consensus price target of $8.25, suggesting a potential upside of 11.49%. Given Select Medical's stronger consensus rating and higher probable upside, equities research analysts clearly believe Select Medical is more favorable than Owens & Minor.

Volatility and Risk

Select Medical has a beta of 1.43, indicating that its share price is 43% more volatile than the S&P 500. Comparatively, Owens & Minor has a beta of 0.14, indicating that its share price is 86% less volatile than the S&P 500.

Profitability

This table compares Select Medical and Owens & Minor's net margins, return on equity and return on assets.

Insider and Institutional Ownership

76.1% of Select Medical shares are owned by institutional investors. Comparatively, 87.5% of Owens & Minor shares are owned by institutional investors. 19.7% of Select Medical shares are owned by insiders. Comparatively, 2.2% of Owens & Minor shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Select Medical beats Owens & Minor on 12 of the 14 factors compared between the two stocks.

Cantel Medical (NYSE:CMD) and Owens & Minor (NYSE:OMI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, institutional ownership, earnings and profitability.

Volatility & Risk

Cantel Medical has a beta of 1.27, indicating that its share price is 27% more volatile than the S&P 500. Comparatively, Owens & Minor has a beta of 0.14, indicating that its share price is 86% less volatile than the S&P 500.

Valuation and Earnings

This table compares Cantel Medical and Owens & Minor's gross revenue, earnings per share and valuation.

Cantel Medical has higher earnings, but lower revenue than Owens & Minor. Owens & Minor is trading at a lower price-to-earnings ratio than Cantel Medical, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

95.4% of Cantel Medical shares are held by institutional investors. Comparatively, 87.5% of Owens & Minor shares are held by institutional investors. 10.9% of Cantel Medical shares are held by company insiders. Comparatively, 2.2% of Owens & Minor shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Cantel Medical and Owens & Minor, as reported by MarketBeat.com.

Cantel Medical presently has a consensus price target of $65.00, suggesting a potential upside of 50.12%. Owens & Minor has a consensus price target of $8.25, suggesting a potential upside of 11.49%. Given Cantel Medical's stronger consensus rating and higher probable upside, equities research analysts clearly believe Cantel Medical is more favorable than Owens & Minor.

Dividends

Cantel Medical pays an annual dividend of $0.21 per share and has a dividend yield of 0.5%. Owens & Minor pays an annual dividend of $0.01 per share and has a dividend yield of 0.1%. Cantel Medical pays out 8.9% of its earnings in the form of a dividend. Owens & Minor pays out 1.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cantel Medical has raised its dividend for 6 consecutive years and Owens & Minor has raised its dividend for 20 consecutive years.

Profitability

This table compares Cantel Medical and Owens & Minor's net margins, return on equity and return on assets.

Summary

Cantel Medical beats Owens & Minor on 14 of the 17 factors compared between the two stocks.

Xencor (NASDAQ:XNCR) and Owens & Minor (NYSE:OMI) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, analyst recommendations, valuation and profitability.

Institutional and Insider Ownership

90.0% of Xencor shares are owned by institutional investors. Comparatively, 87.5% of Owens & Minor shares are owned by institutional investors. 3.7% of Xencor shares are owned by insiders. Comparatively, 2.2% of Owens & Minor shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent recommendations for Xencor and Owens & Minor, as reported by MarketBeat.com.

Xencor currently has a consensus target price of $40.50, indicating a potential upside of 26.76%. Owens & Minor has a consensus target price of $8.25, indicating a potential upside of 11.49%. Given Xencor's stronger consensus rating and higher possible upside, equities analysts clearly believe Xencor is more favorable than Owens & Minor.

Risk & Volatility

Xencor has a beta of 1.07, suggesting that its share price is 7% more volatile than the S&P 500. Comparatively, Owens & Minor has a beta of 0.14, suggesting that its share price is 86% less volatile than the S&P 500.

Valuation and Earnings

This table compares Xencor and Owens & Minor's gross revenue, earnings per share and valuation.

Xencor has higher earnings, but lower revenue than Owens & Minor. Owens & Minor is trading at a lower price-to-earnings ratio than Xencor, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Xencor and Owens & Minor's net margins, return on equity and return on assets.

Summary

Xencor beats Owens & Minor on 8 of the 14 factors compared between the two stocks.

Ligand Pharmaceuticals (NASDAQ:LGND) and Owens & Minor (NYSE:OMI) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, analyst recommendations, valuation and profitability.

Valuation and Earnings

This table compares Ligand Pharmaceuticals and Owens & Minor's gross revenue, earnings per share and valuation.

Ligand Pharmaceuticals has higher earnings, but lower revenue than Owens & Minor. Owens & Minor is trading at a lower price-to-earnings ratio than Ligand Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

87.5% of Owens & Minor shares are owned by institutional investors. 8.4% of Ligand Pharmaceuticals shares are owned by insiders. Comparatively, 2.2% of Owens & Minor shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Profitability

This table compares Ligand Pharmaceuticals and Owens & Minor's net margins, return on equity and return on assets.

Risk & Volatility

Ligand Pharmaceuticals has a beta of 1.64, suggesting that its share price is 64% more volatile than the S&P 500. Comparatively, Owens & Minor has a beta of 0.14, suggesting that its share price is 86% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of recent recommendations for Ligand Pharmaceuticals and Owens & Minor, as reported by MarketBeat.com.

Ligand Pharmaceuticals currently has a consensus target price of $169.00, indicating a potential upside of 50.61%. Owens & Minor has a consensus target price of $8.25, indicating a potential upside of 11.49%. Given Ligand Pharmaceuticals' stronger consensus rating and higher possible upside, equities analysts clearly believe Ligand Pharmaceuticals is more favorable than Owens & Minor.

Summary

Ligand Pharmaceuticals beats Owens & Minor on 9 of the 14 factors compared between the two stocks.

AtriCure (NASDAQ:ATRC) and Owens & Minor (NYSE:OMI) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, valuation, analyst recommendations and dividends.

Earnings and Valuation

This table compares AtriCure and Owens & Minor's revenue, earnings per share (EPS) and valuation.

AtriCure has higher earnings, but lower revenue than Owens & Minor. AtriCure is trading at a lower price-to-earnings ratio than Owens & Minor, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

89.9% of AtriCure shares are held by institutional investors. Comparatively, 87.5% of Owens & Minor shares are held by institutional investors. 5.8% of AtriCure shares are held by company insiders. Comparatively, 2.2% of Owens & Minor shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares AtriCure and Owens & Minor's net margins, return on equity and return on assets.

Volatility and Risk

AtriCure has a beta of 0.81, meaning that its stock price is 19% less volatile than the S&P 500. Comparatively, Owens & Minor has a beta of 0.14, meaning that its stock price is 86% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings for AtriCure and Owens & Minor, as provided by MarketBeat.

AtriCure currently has a consensus price target of $46.2222, indicating a potential upside of 5.67%. Owens & Minor has a consensus price target of $8.25, indicating a potential upside of 11.49%. Given Owens & Minor's higher possible upside, analysts plainly believe Owens & Minor is more favorable than AtriCure.

Tenet Healthcare (NYSE:THC) and Owens & Minor (NYSE:OMI) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, valuation, analyst recommendations and dividends.

Analyst Recommendations

This is a breakdown of recent ratings for Tenet Healthcare and Owens & Minor, as provided by MarketBeat.

Tenet Healthcare currently has a consensus price target of $28.1818, indicating a potential upside of 58.50%. Owens & Minor has a consensus price target of $8.25, indicating a potential upside of 11.49%. Given Tenet Healthcare's stronger consensus rating and higher possible upside, analysts plainly believe Tenet Healthcare is more favorable than Owens & Minor.

Earnings and Valuation

This table compares Tenet Healthcare and Owens & Minor's revenue, earnings per share (EPS) and valuation.

Owens & Minor has lower revenue, but higher earnings than Tenet Healthcare. Tenet Healthcare is trading at a lower price-to-earnings ratio than Owens & Minor, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

Tenet Healthcare has a beta of 2.33, meaning that its stock price is 133% more volatile than the S&P 500. Comparatively, Owens & Minor has a beta of 0.14, meaning that its stock price is 86% less volatile than the S&P 500.

Insider & Institutional Ownership

99.6% of Tenet Healthcare shares are held by institutional investors. Comparatively, 87.5% of Owens & Minor shares are held by institutional investors. 1.7% of Tenet Healthcare shares are held by company insiders. Comparatively, 2.2% of Owens & Minor shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Tenet Healthcare and Owens & Minor's net margins, return on equity and return on assets.

Summary

Tenet Healthcare beats Owens & Minor on 10 of the 13 factors compared between the two stocks.